Trial · NCT00839527
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period (TP) (156 Weeks) | STARTED | Placebo + Metformin + Glimepiride | 115 | |
| Treatment Period (TP) (156 Weeks) | STARTED | Pioglitazone + Metformin + Glimepiride | 277 | |
| Treatment Period (TP) (156 Weeks) | STARTED | Albiglutide + Metformin + Glimepiride | 271 | |
| Treatment Period (TP) (156 Weeks) | COMPLETED | Placebo + Metformin + Glimepiride | 55 | |
| Treatment Period (TP) (156 Weeks) | COMPLETED | Pioglitazone + Metformin + Glimepiride | 159 | |
| Treatment Period (TP) (156 Weeks) | COMPLETED | Albiglutide + Metformin + Glimepiride | 152 | |
| Treatment Period (TP) (156 Weeks) | NOT COMPLETED | Placebo + Metformin + Glimepiride | 60 | |
| Treatment Period (TP) (156 Weeks) | NOT COMPLETED | Pioglitazone + Metformin + Glimepiride | 118 | |
| Treatment Period (TP) (156 Weeks) | NOT COMPLETED | Albiglutide + Metformin + Glimepiride | 119 | |
| Follow-up Period (FUP) (8 Weeks) | STARTED | Placebo + Metformin + Glimepiride | 114 | |
| Follow-up Period (FUP) (8 Weeks) | STARTED | Pioglitazone + Metformin + Glimepiride | 273 | |
| Follow-up Period (FUP) (8 Weeks) | STARTED | Albiglutide + Metformin + Glimepiride | 266 | |
| Follow-up Period (FUP) (8 Weeks) | COMPLETED | Placebo + Metformin + Glimepiride | 86 | |
| Follow-up Period (FUP) (8 Weeks) | COMPLETED | Pioglitazone + Metformin + Glimepiride | 217 | |
| Follow-up Period (FUP) (8 Weeks) | COMPLETED | Albiglutide + Metformin + Glimepiride | 204 | |
| Follow-up Period (FUP) (8 Weeks) | NOT COMPLETED | Placebo + Metformin + Glimepiride | 28 | |
| Follow-up Period (FUP) (8 Weeks) | NOT COMPLETED | Pioglitazone + Metformin + Glimepiride | 56 | |
| Follow-up Period (FUP) (8 Weeks) | NOT COMPLETED | Albiglutide + Metformin + Glimepiride | 62 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00839527/flow